Is there a need for new antifungal agents?
de Pauw
B
B
Department of Haematology, University Hospital St Radboud, Nijmegen, The Netherlands. b.depauw@hemat.azn.nl
D000666:Amphotericin B / Q000009:adverse effects / Q000627:therapeutic use; D000077612:Anidulafungin; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D054714:Echinocandins; D005656:Fungal Proteins; D006801:Humans; D009181:Mycoses / Q000188:drug therapy; D010455:Peptides; D010456:Peptides, Cyclic / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D054714:Echinocandins; D005656:Fungal Proteins; D010455:Peptides; D010456:Peptides, Cyclic; D000666:Amphotericin B; D000077612:Anidulafungin; C007572:echinocandin B